Pharsight® Events Archive - Seminars
Best Practice Strategies and Technology for Maximizing Your Probability of Drug Development Success
May 2 (Munich, Germany) and May 4 (Paris, France), 2011
This seminar covers real-world strategies to overcome many of the obstacles facing senior managers in small to mid-sized pharmaceutical and biotechnology companies. Learn about how Pharsight's flexible offerings of PK/PD analysis support for submission, drug-disease-trial modeling and simulation, and software technologies are helping drug development organizations manage the challenges of:
- Standardizing data early in development for downstream decisions and to enhance the value of a company's product portfolio.
- Building data and submissions capabilities through effective partnering and outsourcing, including choosing vendors that support standards such as CDISC and eCTD.
- Minimizing study costs and optimizing study design through proper powering of patient enrollment and trial duration.
Selected Presentations
Turning Preclinical/Clinical Data Into Knowledge and Deriving Value
Henri Merdjan,
Pharm, AIHP
Senior Director, Pharsight Consulting Services Europe
View Presentation 
®
Novexel Case Study: Using PKPD Data to Accelerate Business Development
Aram Mangasarian, Ph.D., MBA
Chief Business Officer, Noxxon Pharma AG
View Presentation
Building Value Through Strategic Data Analysis: Case Studies
Jonathan K. Wagg, M.D., Ph.D.
Senior Scientist, Pharsight Consulting Services
View Presentation
A Modeling and Simulation Framework to Support Oncology Drug Development Decisions
Christine Falcoz, Ph.D, Senior Scientist
Rene Bruno, Ph.D., Managing Director
Pharsight Consulting Services
View Presentation
Pharsight would welcome the opportunity to collaborate with your organization. Contact Us Now